CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- SC 13G/A Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC 13G/A Stake Amended Statement of Ownership
- S-3 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 4 Open-market sale SVP, Finance & Accounting sold 2,318 shares at $17.80 ($41,262)
- 4 Open-market sale Chief Legal Officer sold 2,053 shares at $17.80 ($36,544)
- 4 Open-market sale Chief Operating Officer sold 1,496 shares at $17.80 ($26,630)
Page 12 of 41 · 809 filings